Acute cardiac overload does not induce cardiac or skeletal expression of fibroblast growth factor 23 in rats

Abul Fajol1,2, Hirotaka Komaba1,2,3, Chigusa Ishioka1,2

  • 1Division of Nephrology, Endocrinology and Metabolism.

Insights

Acute cardiac overload in rats did not increase fibroblast growth factor 23 (FGF23) levels or expression. This suggests that significant cardiac damage is necessary to induce FGF23 production.

Area of Science:

  • Cardiovascular Biology
  • Endocrinology
  • Mineral Metabolism

Background:

  • Elevated fibroblast growth factor 23 (FGF23) is linked to cardiovascular events, including heart failure.
  • While FGF23 can induce cardiac hypertrophy, recent findings indicate that cardiac hypertrophy and myocardial infarction stimulate FGF23 production in cardiomyocytes.

Purpose of the Study:

  • To investigate if acute cardiac overload increases cardiac and skeletal FGF23 expression.
  • To determine if acute cardiac overload elevates circulating FGF23 levels.

Main Methods:

  • Acute cardiac overload was induced in rats via intraperitoneal injection of isotonic saline.
  • Serum FGF23 levels and mineral metabolism parameters were measured at 2, 6, and 24 hours post-injection.
  • Cardiac and skeletal tissue gene expression (FGF23) was analyzed.

Main Results:

  • Saline injection successfully induced acute cardiac overload, shown by increased brain natriuretic peptide and atrial natriuretic peptide expression.
  • No significant changes were observed in serum FGF23 levels.
  • Cardiac, calvarium, and femur FGF23 gene expression remained unchanged.

Conclusions:

  • Acute cardiac overload, induced by saline injection in rats, does not elevate FGF23 expression or serum levels.
  • These results imply that more severe or prolonged cardiac damage may be required to trigger FGF23 induction.